Michael H. Carrel - 20 Jul 2026 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Reporting relationship: Director
Issuer ticker: INSP
Reported as of: 20 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jul 2026, 19:10:21 UTC
Prior SEC filing: 02 Jul 2026
Next SEC filing: 03 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Bryan Phillips, Attorney-in-Fact for Michael H. Carrel

Key filing fact

Michael H. Carrel filed Form 4 for Inspire Medical Systems, Inc. (INSP) on 27 Jul 2026.

Key facts

This page summarizes Michael H. Carrel's Form 4 filing for Inspire Medical Systems, Inc. (INSP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Jul 2026, 19:10.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001230584 Primary reporting owner

CARREL MICHAEL H

Relationship: Director
Address: C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY
Signature: /s/ Bryan Phillips, Attorney-in-Fact for Michael H. Carrel
Signature date: 27 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSP transaction

Common Stock

Award

Transaction value
Shares: +5,631
Change %
Price: $0.000000^*
Shares after: 5,631
Date: 20 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in three equal annual installments on the first three anniversaries of the date of grant, subject to the Reporting Person's continued service on the board of directors of the Issuer through each such vesting date.